Over-the-Counter Drugs May Home Promise for Alzheimer's
Schieszer, John, St Louis Post-Dispatch (MO)
Some medicines already on drugstore shelves may turn out to slow - or even prevent - the onset of Alzheimer's disease.
Researchers in St. Louis and elsewhere are studying nonsteriodal anti-inflammatory drugs (NSAIDs) and estrogen replacement therapy to see the effect they might have on Alzheimer's.
In one of the most promising studies so far, Dr. Louis Kirby of the Sun Health Research Institute in Sun City, Ariz., has found that one medication, indomethacin (Indocin), was able to improve mental capabilities in moderately impaired Alzheimer's disease patients after they took it for only six months.
"This has caused a stir in the industry. Everyone is …
The rest of this article is only available to active members of Questia
Sign up now for a free, 1-day trial and receive full access to:
- Questia's entire collection
- Automatic bibliography creation
- More helpful research tools like notes, citations, and highlights
- Ad-free environment
Already a member? Log in now.
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information:
Article title: Over-the-Counter Drugs May Home Promise for Alzheimer's.
Contributors: Schieszer, John - Author.
Newspaper title: St Louis Post-Dispatch (MO).
Publication date: November 13, 1994.
Page number: 15.
© 2008 St. Louis Post-Dispatch.
Provided by ProQuest LLC. All Rights Reserved.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.
One moment ...
- Georgia
- Arial
- Times New Roman
- Verdana
- Courier/monospaced
Reset